Antinociceptive effects of morphine were different between experimental and genetic diabetes

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 4, 1998, Pages 889-897

  Takeshita, Nobuaki ^a   Yamaguchi, Isamu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

5 Hydroxytryptamine; Antinociception; Diabetic mice; Dopamine; Formalin test; Morphine

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; FENCLONINE; FR 64822; KETANSERIN; MORPHINE; N (4 PYRIDYLCARBAMOYL)AMINO 1,2,3,6 TETRAHYDROPYRIDINE; PINDOLOL; SEROTONIN AGONIST; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; HEREDITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANALGESICS, OPIOID; ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FORMALDEHYDE; MALE; MICE; MORPHINE; PAIN MEASUREMENT; SEROTONIN AGONISTS;

ANIMALIA;

EID: 0031828779     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00061-6     Document Type: Article

References (37)

1. Brase D.A., Han Y.-H., Dewey W.L. Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes. 36:1987;1173-1177.
2. Cicero T.J., Meyer E.R., Smithloff B.R. Alpha adrenergic blocking agents. Antinociceptive activity and enhancement of morphine-induced analgesia J. Pharmacol. Exp. Ther. 189:1974;72-82.
3. Coderre T.J., Vaccarino A.L., Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 535:1990;155-158.
4. Crandall E.A., Gillis M.A., Fernstrom J.D. Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats. Endocrinology. 109:1981;310-312.
5. Crisp T., Smith D.J. A local serotonergic component involved in the spinal antinociceptive action of morphine. Neuropharmacology. 28:1989;1047-1053.
6. Crisp T., Stafinsky J.L., Uram M., Perni V.C., Weaver M.F., Spanos L.J. Serotonin contributes to the spinal antinociceptive effects of morphine. Pharmacol. Biochem. Behav. 39:1991;591-595.
7. Dennis S.G., Melzack R., Gutman S., Boucher F. Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci. 26:1980;1247-1259.
8. Dewey W.L., Harris L.S., Howes J.F., Nuite J.A. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 175:1970;435-442.
9. Dubuisson D., Dennis S.G. The formalin test. A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain. 4:1977;161-174.
10. Fennessy M.R., Lee J.R. Modification of morphine analgesia by drugs affecting adrenergic and tryptaminergic mechanisms. J. Pharm. Pharmacol. 22:1970;930-935.
11. Greenberg J., Ellyin F., Pullen G., Ehrenpreis S., Singh S.P., Cheng J. Methionine-enkephalin and β-endorphin levels in brain, pancreas, and adrenals of db/db mice. Endocrinology. 116:1985;328-331.
12. Heller B., Saavedra J.M., Fischer E. Influence of adrenergic blocking agents upon morphine and catecholamine analgesic effect. Experientia. 24:1968;804-805.
13. Hunskaar S., Fasmer O.B., Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J. Neurosci. Methods. 14:1985;69-76.
14. Izenwasser S., Kornetsky C. Effects of clonidine and yohimbine, alone and in combination with morphine, on supraspinal analgesia. Neuropharmacology. 29:1990;25-29.
15. Kamei J., Ohhashi Y., Aoki T., Kawasima N., Kasuya Y. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists. Brain Res. 571:1992;199-203.
16. Kamei J., Hitosugi H., Kasuya Y. Formalin-induced nociceptive responses in diabetic mice. Neurosci. Lett. 149:1993;161-164.
17. Kodama H., Fujita M., Yamaguchi I. Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice. Diabetologia. 37:1994;739-744.
18. Lackovic Z., Salkovic M., Kuci Z., Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54:1990;143-147.
19. Lin Y., Morrow T.J., Kiritsy-Roy J.A., Terry L.C., Casey K.L. Cocaine. Evidence for supraspinal, dopamine-mediated, non-opiate analgesia Brain Res. 479:1989;306-312.
20. Major C.T., Pleuvry B.J. Effects of α-methyl-p-tyrosine, p-chlorophenylalanine, L-β-(3,4-dihydroxyphenyl)alanine, 5-hydroxytryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse. Br. J. Pharmacol. 42:1971;512-521.
21. Morgan M.J., Franklin K.B.J. 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res. 519:1990;144-149.
22. Morgan M.J., Franklin K.B.J. Dopamine receptor subtypes and formalin test analgesia. Pharmacol. Biochem. Behav. 40:1991;317-322.
23. Ohkubo Y., Nomura K., Yamaguchi I. Involvement of dopamine in the mechanism of action of FR64822, a novel non-opioid antinociceptive compound. Eur. J. Pharmacol. 204:1991;121-125.
24. Oluyomi A.O., Hart S.L., Smith T.W. Differential antinociceptive effects of morphine and methylmorphine in the formalin test. Pain. 49:1992;415-418.
25. Paalzow G., Paalzow L. Morphine-induced inhibition of different pain responses in relation to the regional turnover of rat brain noradrenaline and dopamine. Psychopharmacology (Berlin). 45:1975;9-20.
26. Richardson B.P. Serotonin and nociception. Ann. NY Acad. Sci. 600:1990;511-520.
27. Sethy V.H., Pradhan R.J., Mandrekar S.S., Sheth U.K. Role of catecholamines in morphine and meperidine analgesia. Indian J. Med. Res. 58:1970;1453-1458.
28. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test. Characteristic biphasic pain response Pain. 38:1989;347-352.
29. Shimomura Y., Shimizu H., Takahashi M., Sato N., Uehara Y., Suwa K., Kobayashi I., Tadokoro S., Kobayashi S. Changes in ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats. Endocrinology. 123:1988;2621-2625.
30. Simon G.S., Dewey W.L. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J. Pharmacol. Exp. Ther. 218:1981;318-323.
31. Takeshita N., Ohkubo Y., Yamaguchi I. Tiapride attenuates pain transmission through an indirect activation of serotonergic mechanism. J. Pharmacol. Exp. Ther. 275:1995;23-30.
32. Takeshita N., Yamaguchi I. Insulin attenuates formalin-induced nociceptive response in mice through a mechanism which is deranged by diabetes mellitus. J. Pharmacol. Exp. Ther. 281:1997;315-321.
33. 3H]spiroperidol binding in streptozotocin-diabetic rats. J. Neurochem. 40:1983;1456-1459.
34. Trulson M.E., Himmel C.D. Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats. J. Neurochem. 44:1985;1873-1876.
35. Trulson M.E., Jacoby J.H., MacKenzie R.G. Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. J. Neurochem. 46:1986;1068-1072.
36. Vaccarino A.L., Melzack R. Temporal processes of formalin pain. Differential role of the cingulum bundle, fornix pathway and medial bulboreticular formation Pain. 49:1992;257-271.
37. Vaccarino A.L., Chorney D.A. Descending modulation of central neural plasticity in the formalin pain test. Brain Res. 666:1994;104-108.